We are live on
!
Find out more
TA
TruWealth Advisors Portfolio holdings
AUM
$2.08B
1-Year Est. Return
21.15%
This Fund
S&P 500
This Quarter
Est. Return
-1.77%
1 Year Est. Return
+21.15%
3 Year Est. Return
+56.32%
5 Year Est. Return
+63.84%
10 Year Est. Return
–
AUM
$1.66B
AUM Growth
-$1.75M
(-0.11%)
Cap. Flow
+$40.6M
Cap. Flow
% of AUM
2.45%
Top 10 Holdings %
Top 10 Hldgs %
45.05%
Holding
171
New
8
Increased
81
Reduced
50
Closed
13
Top Buys
| 1 |
PIMCO Multi Sector Bond Active ETF
PYLD
|
+$14.9M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$11.8M |
| 3 |
Invesco S&P MidCap Quality ETF
XMHQ
|
+$8.87M |
| 4 |
Freeport-McMoran
FCX
|
+$7.27M |
| 5 |
Janus Henderson AAA CLO ETF
JAAA
|
+$6.97M |
Top Sells
| 1 |
Vanguard Total Stock Market ETF
VTI
|
+$14.9M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$8.96M |
| 3 |
IBM
IBM
|
+$5.62M |
| 4 |
Lockheed Martin
LMT
|
+$4.98M |
| 5 |
AbbVie
ABBV
|
+$4.45M |
Sector Composition
| 1 | Technology | 9.44% |
| 2 | Healthcare | 5.19% |
| 3 | Financials | 4.17% |
| 4 | Energy | 3.96% |
| 5 | Communication Services | 2.79% |
Similar funds
AG
ACP
TP
NSUP
ACG
DDPIC
NSCM
SW
TruWealth Advisors's Q1 2025 Portfolio in Review
As of Q1 2025, TruWealth Advisors held 171 positions worth $1.66B, down 0.11% from $1.66B the previous quarter. Its ten largest holdings account for 45% of the portfolio.
TruWealth Advisors's Q1 2025 filing shows 8 new, 81 increased, 50 reduced and 13 closed positions. Its largest new stake was Bristol-Myers Squibb: 202,426 shares worth $12.3M. The largest sale was Vanguard Total Stock Market ETF, an estimated $14.9M.
By sector, the portfolio is most concentrated in Technology at 9.4% of assets, down from 11% a quarter earlier, followed by Healthcare and Financials.
- TruWealth Advisors's largest Q1 2025 buy was Bristol-Myers Squibb: 202,426 shares worth $12.3M.
- TruWealth Advisors added most to PIMCO Multi Sector Bond Active ETF in Q1 2025, an estimated $14.9M increase.
- TruWealth Advisors's biggest Q1 2025 reduction was Vanguard Total Stock Market ETF, cutting an estimated $14.9M.
- TruWealth Advisors fully exited Vertex Pharmaceuticals in Q1 2025, selling an estimated $8.96M.
- TruWealth Advisors's ten largest holdings make up 45% of its $1.66B portfolio in Q1 2025.
- TruWealth Advisors opened 8 new positions and closed 13 in Q1 2025.
- TruWealth Advisors's portfolio value fell 0.11% quarter-over-quarter to $1.66B.
Based on TruWealth Advisors's 13F filing for Q1 2025, filed 10 Apr 2025.